What Qinecsa Solutions does

Qinecsa Solutions is a UK-incorporated, privately held pharmacovigilance technology and services company serving pharmaceutical, biotechnology, medical device, and public health organizations globally. Founded in 2011 and headquartered at 2 Leman Street, London, the company positions itself as a full-lifecycle drug safety partner rather than a point-solution vendor.

The company's offering is built around three proprietary SaaS platforms — Reportum (unified, direct-from-source adverse event intake integrated with Argus, ArisGlobal, Veeva Safety, CRM, and EDC systems), HaloPV (a cloud-native, modular platform automating PSMF management, periodic reporting, local ICSR management, and vendor oversight, currently at version 6.2), and Vigilance Workbench (signal detection and management built by pioneers in advanced safety signalling and trusted by top 10 global pharma). These platforms are complemented by a broad professional services portfolio covering case management, clinical safety management, signal and risk management, medical writing, quality and compliance, PV consulting, healthcare analytics, a 24/7 multilingual medical information call center supporting 800+ products, and medical device vigilance. AI and NLP are applied at the workflow layer, notably for intake automation and literature screening.

Qinecsa generates revenue through a mix of subscription SaaS licensing for its platforms, professional services delivered by scientific and regulatory staff, and a technology-enabled managed services model. Pricing is not publicly disclosed and follows an enterprise, consultative sales motion ('Talk to a PV Specialist', 'Schedule a Demo') with annual billing cadence. The company holds ISO 9001, ISO 27001, and Cyber Essentials Plus certifications, operates across Europe, North America, Asia-Pacific, the Middle East, and is pursuing APAC, LATAM, and MENA expansion. Qinecsa has pursued an inorganic growth path, acquiring Commonwealth Informatics in December 2022 and Insife ApS in April 2024, and has recently expanded its C-suite with a new CPO (December 2025) and CCO (January 2026) to support its next growth phase.

Name

Qinecsa Solutions

Legal name

Qinecsa Solutions

Website

https://qinecsa.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Qinecsa Solutions is a UK-headquartered, privately held pharmacovigilance technology and services company serving pharmaceutical, biotechnology, medical device, and public health organizations globally through its proprietary Reportum, HaloPV, and Vigilance Workbench SaaS platforms and a broad drug safety services portfolio.

Ownership category

akta.pro rank

Product category

Pharmacovigilance Software & Drug Safety Services

NAICS

Custom Computer Programming Services (541511), Other Scientific and Technical Consulting Services (54169), Computer Systems Design and Related Services (54151), Telephone Call Centers (56142)

SIC

Services-Computer Programming Services (7371)

akta.pro primary industry

Pharmacovigilance & Drug Safety Software (HLAGAJAK)

akta.pro secondary industries

Medical Review & Pharmacovigilance Quality (PV QA/Audits/SOPs) (HLAGALAH), Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH), PV Regulatory Submissions & Safety Reporting (E2B/CIOMS/Expedited) (HLAGALAJ), Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support) (HLAGALAK), Safety/Pharmacovigilance (PV) & Clinical Safety Systems (HLACAOAH)

Keywords

• Pharmacovigilance software
• Drug safety services
• Adverse event reporting
• Signal detection platform
• Clinical safety management

Headquarters

HQ city

Mysore

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Software Platforms (SaaS): Subscription-based SaaS delivery of pharmacovigilance technology platforms including Reportum, HaloPV, and Vigilance Workbench. These platforms are offered as modular solutions that integrate with existing ecosystems.
2. Professional Services: Comprehensive pharmacovigilance services including case management, clinical safety management, medical writing, signal & risk management, quality & compliance, pharmacovigilance consulting, healthcare analytics, medical information call center, and medical device vigilance. Delivered by expert scientific and regulatory professionals.
3. Technology-Enabled Services: Managed service model delivering benefits of advanced PV technology, automation and AI through fully managed services. Helps organizations modernize faster, improve efficiency, reduce vendor complexity and strengthen compliance without investing in technology platforms internally.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Qinecsa Solutions provides an integrated suite of cloud-native SaaS pharmacovigilance platforms (Reportum for safety intake, HaloPV for full-lifecycle PV automation, and Vigilance Workbench for signal detection) alongside comprehensive drug safety services including case management, clinical safety management, signal and risk management, medical writing, quality and compliance, PV consulting, medical device vigilance, and a 24/7 multilingual medical information call center. The company serves pharmaceutical, biotech, medical device, and public health organizations globally, with technology-enabled managed services bridging platform technology and expert human oversight.

Product overview

Qinecsa Solutions offers a connected product suite and comprehensive services for pharmacovigilance and drug safety. The core product portfolio includes three integrated platforms: Reportum (unified safety intake platform), HaloPV (modular full-lifecycle pharmacovigilance automation platform), and Vigilance Workbench (signal detection and management platform). These platforms work as a cohesive ecosystem designed to eliminate fragmentation across pharmacovigilance processes. The suite is complemented by extensive services including Case Management, Clinical Safety Management, Signal & Risk Management, Medical Writing, Quality & Compliance, Pharmacovigilance Consulting, Healthcare Analytics, Medical Information Call Center, and Medical Device Vigilance. The company also offers specialized solutions for End-to-End Case Management, Next Generation Literature Management with AI, and Quantitative Signal Detection as a Service (QSDaaS). Qinecsa positions itself as a single provider combining both services and platforms to streamline operations and eliminate vendor friction.

Differentiator

Problem solved

Functional benefit

Brands

• Reportum: Market leading unified safety intake platform for adverse event capture and pharmacovigilance reporting
• HaloPV
• Vigilance Workbench (QVW)
• QSDaaS
• Next Generation Literature Management

Products and services

• Reportum Platform Unified, direct-from-source SaaS safety intake platform that captures adverse events across digital and analogue channels, standardizes intake across global stakeholders, and integrates with Argus, ArisGlobal, Veeva Safety, CRM, and EDC systems. Built for pharmaceutical, biotech, and consumer health organizations.
• HaloPV Platform Cloud-native modular full-lifecycle pharmacovigilance platform that automates PSMF management, periodic report scheduling, aggregate reporting coordination (PSURs/PBRERs), local safety ICSR management, and vendor oversight. Integrates with rather than replaces existing safety ecosystems.
• Vigilance Workbench (QVW) Gold standard signal detection and management platform covering the entire signal lifecycle from detection through evaluation, decision-making, and communication. Includes pre-built automated pipelines from FAERS, VAERS, EVDAS, Argus, ArisGlobal, and Veeva.
• Case Management End-to-end pharmacovigilance case management service covering ICSR management, literature screening and review, data migration, medical review of ICSRs, and regulatory submissions for pharmaceutical and biotech sponsors.
• Clinical Safety Management Strategic pharmacovigilance leadership for clinical trials including SAE and SUSAR management, drug safety and reporting training, and safety management plan development.
• Medical Writing Medical writing services for aggregate reports, risk management plans, protocol review, and regulatory submissions aligned with EU GVP, FDA, and ICH guidelines.
• Pharmacovigilance Consulting Strategic and operational pharmacovigilance consulting including management consulting, benchmarking, regulatory intelligence, and pharmacovigilance training to strengthen compliance and operating models.
• Quality & Compliance Quality and compliance services including PV audit-as-a-service, QPPV services, EudraVigilance setup and maintenance, and PSMF setup and maintenance to ensure inspection readiness.
• Signal & Risk Management Advanced signal detection and risk management including signal detection and management, benefit-risk management (RMP, REMS), drug safety physician services, and regulatory responses.
• Local Pharmacovigilance Localized pharmacovigilance expertise ensuring global compliance with country-specific safety requirements, local QPPV and safety officer support, and timely case reporting across markets.
• Healthcare Analytics Healthcare analytics services including Quantitative Signal Detection as a Service (QSDaaS) using advanced statistical methodologies for proactive risk management and data-driven decision-making.
• Medical Information Call Center 24/7 multilingual call center supporting over 800 unique prescription products and medical devices that captures adverse events, product quality complaints, and provides compliant medical information responses.
• Medical Device Vigilance Comprehensive medical device vigilance services for EU MDR, FDA, and global compliance including complaint handling, root cause analysis, risk management, and regulatory reporting.
• Quantitative Signal Detection as a Service (QSDaaS) Quantitative signal detection service combining proven statistical methods and clinical expertise to deliver reliable, actionable safety insights for proactive risk management.

Quantifiable outcome

• 60% reduction in central effort, 45% reduction in local effort, 95% reduction in reconciliation, 40% fewer follow-ups, $30–$50 savings per report, 65% reduction in end-to-end workload
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability6 records

Feature4 records

Partnerships

Six partnerships are on record, tiered core.

• Argus SafetycoreTechnology or IntegrationReportum integrates with Argus Safety (Oracle) database systems, enabling seamless data flow between intake platforms and core safety databases for pharmaceutical companies already using Argus.
• ArisGlobalcoreTechnology or IntegrationReportum integrates with ArisGlobal safety platforms, allowing customers using ArisGlobal LifeSphere solutions to connect intake workflows with aggregate reporting and signal management capabilities.
• Veeva Vault SafetycoreTechnology or IntegrationReportum integrates with Veeva Vault Safety, providing biopharmaceutical companies using Veeva's cloud platform with structured adverse event intake and case management capabilities.
• FAERS (FDA Adverse Event Reporting System)coreTechnology or IntegrationVigilance Workbench includes pre-built automated pipelines from FAERS, enabling organizations to ingest FDA safety data for signal detection and regulatory intelligence purposes.
• VAERS (Vaccine Adverse Event Reporting System)coreTechnology or IntegrationVigilance Workbench connects to VAERS for vaccine safety surveillance, supporting public health organizations and pharmaceutical companies monitoring vaccine safety signals.
• EudraVigilancecoreTechnology or IntegrationVigilance Workbench integrates with EVDAS (EudraVigilance Data Analysis System) outputs, enabling European pharmacovigilance signal detection using EMA data sources.

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• ICON plc: ICON (including PRA Health Sciences) is a top global CRO with substantial pharmacovigilance, clinical safety, and post-marketing services. It competes with Qinecsa's services portfolio across pharma, biotech, and medical device customers.
• IQVIA: IQVIA is the largest global CRO with extensive technology-enabled pharmacovigilance services and proprietary safety analytics. It is a broad incumbent competitor to Qinecsa's professional services line and competes for the same enterprise pharma PV outsourcing budgets.
• Parexel International: Parexel is a large global CRO with significant pharmacovigilance service offerings, including case processing, signal management, and QPPV support. It competes with Qinecsa's services business while also sometimes partnering with PV-software vendors, including as a Veeva partner.
• Labcorp Drug Development (formerly Covance): Labcorp's drug development business offers comprehensive pharmacovigilance, medical writing, and safety services. It is a broad incumbent competing with Qinecsa for enterprise PV outsourcing engagements.

Emerging players

• Saama Technologies: Saama applies AI and data analytics to clinical development and pharmacovigilance workflows. It is an emerging player competing with Qinecsa's AI-driven literature screening and signal-detection capabilities, particularly for biotech customers seeking modern, AI-first PV tooling.

Direct peers

• ArisGlobal: ArisGlobal offers LifeSphere Safety, a leading pharmacovigilance platform covering case management, signal detection, and aggregate reporting. It is the most direct end-to-end competitor to Qinecsa's combined Reportum + HaloPV + Vigilance Workbench offering, targeting the same pharma, biotech, and medical device customer base.
• EXTEDO: EXTEDO provides pharmacovigilance and regulatory affairs software, including safety database and document management solutions. It competes with Qinecsa's HaloPV and Vigilance Workbench in mid-market and large pharma safety-IT buying decisions.
• Veeva Systems (Veeva Vault Safety): Veeva Vault Safety is a cloud-native safety case management and submission platform serving large biopharma. Like Argus, it is both an integration partner for Reportum and a direct competitor in the safety platform layer, and Veeva's broader commercial momentum gives it significant competitive firepower.
• Ennov: Ennov offers a unified pharmacovigilance and regulatory platform (Ennov PV) covering case management, signal detection, and document management. It competes with Qinecsa's integrated PV platform stack and is a recognized alternative for mid-market and emerging-market pharma buyers.
• Oracle Health Sciences (Argus Safety): Oracle's Argus Safety is the dominant safety database in large pharma and a direct competitor to Qinecsa's safety-platform stack. Qinecsa's Reportum integrates with Argus, highlighting both overlap (Qinecsa sits on top of or alongside Argus) and the strategic tension of partnering with the dominant incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/qinecsa
• YouTubeyoutube.com/@QinecsaSolutions
• Facebookfacebook.com/profile.php?id=61557635005234
• LinkedInlinkedin.com/company/qinecsa-solutions

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Qinecsa Solutions